The roll-out of CAR T-cell therapy in the UK
Recent scientific advances in MPNs
AML & Myelodysplasia breakthrough
Karthik Ramasamy | EBMT 2019 | Clinical decisions based on patient quality-of-life in MM
Discontinuing treatment and predicting relapse in CML
How can translational studies improve patient outcomes?
Prof Paresh Vyas talk about personalised medicine and blood cancers
Oxford Blood Group
CAMELLIA thank you video
Treatment of leukaemia – lecture by Paresh Vyas
Leukaemia – Will we ever understand what is going on? – Paresh Vyas Open Weeks 2015
Iron and infection – podcast with Dr Hal Drakesmith
Blood diseases – lecture by Dr Adam Mead
Paresh Vyas: Oxford Centre for Haematology Series
One patient's reality of living with MDS
Highlights of progress in MDS
Research into MDS
Is there a link between radiation and MDS?
Brief explanation of NICE
Iron overload and MDS
Is there an age limit to treatments for MDS?
Is there a link between MDS and polymyalgia?
Haplo and Cord transplants
Chromosomes and MDS
Is MDS hereditary?
Graft versus Leukaemia and Graft versus Host
CAR-T therapy
Gene mutations in MDS
What can cause MDS to occur?
Blasts and Sideroblasts in MDS
Prof Paresh Vyas talk about personalised medicine and blood cancers